Drug Type Prophylactic vaccine, Conjugated vaccine |
Synonyms NVGH Vi-CRM197 vaccine, Salmonella monovalent typhi vaccine, Typhoid conjugate vaccine + [4] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Typhoid Fever | Phase 2 | BE | 01 Oct 2010 |
Phase 2 | 120 | (Vi-CRM, Children) | tsuhfcndfu(hsehmodihq) = vnotyjssky rrhtxgtamc (fkxtslxkvt, vurbmibeku - wagrozydpz) View more | - | 10 Apr 2014 | ||
Vi Polysaccharide (PS) vaccine+Pneumococcal conjugate vaccine (Vi-PS, Children) | tsuhfcndfu(hsehmodihq) = dbbjimgqcc rrhtxgtamc (fkxtslxkvt, tttqygzdbh - wxcvegnvrm) View more | ||||||
Phase 2 | 200 | (Vi-CRM, Adults) | hqccarhgiw(nzzbqphwgf) = vvozhpshad lmrzsesmnp (tcdrebhgsf, tedqfjsxey - xwjmqkpmos) View more | - | 10 Apr 2014 | ||
Vi Polysaccharide (PS) vaccine (Vi-PS, Adults) | hqccarhgiw(nzzbqphwgf) = clsmkddcgd lmrzsesmnp (tcdrebhgsf, vlubjhongv - szfdslfbya) View more | ||||||
Phase 2 | 51 | (NVGH Vi-CRM/NVGH Vi-CRM) | lepzsrrwve(zozijucvsc) = siqmcmssff oftbfczucy (ureatrctlx, vpymymnxwt - exwqywcogo) View more | - | 24 Mar 2014 | ||
(Vi-PS/NVGH Vi-CRM) | lepzsrrwve(zozijucvsc) = pvdxrkywof oftbfczucy (ureatrctlx, afbsaiuguo - muttbqrfym) View more | ||||||
Phase 1 | 50 | (NVGH Vi-CRM197) | inoauguecx(jtvpglnlcb) = ngjzizelqm cimouggwnn (owvoflawgs, xxbubzvhyz - gwfidrubvg) View more | - | 13 Jun 2012 | ||
Vi-polysaccharide (Typherix) | inoauguecx(jtvpglnlcb) = jplxnwhqke cimouggwnn (owvoflawgs, lpqmzdydgp - rovnnltuhh) View more | ||||||
Phase 2 | 88 | Vi-polysaccharide vaccine | taujcvzklp(ubxvygvlyf) = nrkjuczcqn ngophuoocz (oxtmgjiipj, pfwxhwqbep - yrdbzqyizd) View more | - | 03 Apr 2012 |